202 related articles for article (PubMed ID: 30483821)
1. Interleukin-23 receptor signaling mediates cancer dormancy and radioresistance in human esophageal squamous carcinoma cells via the Wnt/Notch pathway.
Zhou Y; Su Y; Zhu H; Wang X; Li X; Dai C; Xu C; Zheng T; Mao C; Chen D
J Mol Med (Berl); 2019 Feb; 97(2):177-188. PubMed ID: 30483821
[TBL] [Abstract][Full Text] [Related]
2. PI3Kα inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment.
Shi JJ; Xing H; Wang YX; Zhang X; Zhan QM; Geng MY; Ding J; Meng LH
Cancer Lett; 2019 Sep; 459():145-155. PubMed ID: 31173854
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor NFE2L3 promotes the proliferation of esophageal squamous cell carcinoma cells and causes radiotherapy resistance by regulating IL-6.
Chen T; Xu B; Chen H; Sun Y; Song J; Sun X; Zhang X; Hua W
Comput Methods Programs Biomed; 2022 Nov; 226():107102. PubMed ID: 36108571
[TBL] [Abstract][Full Text] [Related]
4. Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation.
Zhang H; Luo H; Hu Z; Peng J; Jiang Z; Song T; Wu B; Yue J; Zhou R; Xie R; Chen T; Wu S
Oncotarget; 2015 Mar; 6(8):6218-34. PubMed ID: 25749038
[TBL] [Abstract][Full Text] [Related]
5. Population and single‑cell transcriptome analyses reveal diverse transcriptional changes associated with radioresistance in esophageal squamous cell carcinoma.
Wu H; Yu J; Kong D; Xu Y; Zhang Z; Shui J; Li Z; Luo H; Wang K
Int J Oncol; 2019 Dec; 55(6):1237-1248. PubMed ID: 31638164
[TBL] [Abstract][Full Text] [Related]
6. WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma.
Abbaszadegan MR; Riahi A; Forghanifard MM; Moghbeli M
Cell Mol Biol Lett; 2018; 23():42. PubMed ID: 30202417
[TBL] [Abstract][Full Text] [Related]
7. Elevated TAB182 enhances the radioresistance of esophageal squamous cell carcinoma through G2-M checkpoint modulation.
Cao Y; Gao A; Li X; Min H; He C; Sun X; Ding WQ; Zhou J
Cancer Med; 2021 May; 10(9):3101-3112. PubMed ID: 33787085
[TBL] [Abstract][Full Text] [Related]
8. The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma.
Zhang H; Si J; Yue J; Ma S
J Cancer Res Clin Oncol; 2021 May; 147(5):1275-1286. PubMed ID: 33687564
[TBL] [Abstract][Full Text] [Related]
9. HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo.
Xi R; Pan S; Chen X; Hui B; Zhang L; Fu S; Li X; Zhang X; Gong T; Guo J; Zhang X; Che S
Oncotarget; 2016 Aug; 7(35):57050-57065. PubMed ID: 27489353
[TBL] [Abstract][Full Text] [Related]
10. High mobility group box 1 promotes radioresistance in esophageal squamous cell carcinoma cell lines by modulating autophagy.
Ma H; Zheng S; Zhang X; Gong T; Lv X; Fu S; Zhang S; Yin X; Hao J; Shan C; Huang S
Cell Death Dis; 2019 Feb; 10(2):136. PubMed ID: 30755598
[TBL] [Abstract][Full Text] [Related]
11. CD59 is a potential biomarker of esophageal squamous cell carcinoma radioresistance by affecting DNA repair.
Zhou Y; Chu L; Wang Q; Dai W; Zhang X; Chen J; Li L; Ding P; Zhang L; Gu H; Li L; Lv X; Zhang W; Zhou D; Zhang P; Cai G; Zhao K; Hu W
Cell Death Dis; 2018 Aug; 9(9):887. PubMed ID: 30166523
[TBL] [Abstract][Full Text] [Related]
12. NOTCH and Esophageal Squamous Cell Carcinoma.
Li Y; Li Y; Chen X
Adv Exp Med Biol; 2021; 1287():59-68. PubMed ID: 33034026
[TBL] [Abstract][Full Text] [Related]
13. TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin.
Jiang Y; Zhang J; Zhao J; Li Z; Chen H; Qiao Y; Chen X; Liu K; Dong Z
BMC Cancer; 2019 Dec; 19(1):1264. PubMed ID: 31888532
[TBL] [Abstract][Full Text] [Related]
14. SOX2/SALL4 stemness axis modulates Notch signaling genes to maintain self-renewal capacity of esophageal squamous cell carcinoma.
Forghanifard MM; Kasebi P; Abbaszadegan MR
Mol Cell Biochem; 2021 Feb; 476(2):921-929. PubMed ID: 33098486
[TBL] [Abstract][Full Text] [Related]
15. Secreted recombinant human IL-24 protein inhibits the proliferation of esophageal squamous cell carcinoma Eca-109 cells in vitro and in vivo.
Ma Q; Jin B; Zhang Y; Shi Y; Zhang C; Luo D; Wang P; Duan C; Song H; Li X; Deng X; Chen Z; Wang Z; Jiang H; Liu Y
Oncol Rep; 2016 May; 35(5):2681-90. PubMed ID: 26935394
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma.
Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869
[TBL] [Abstract][Full Text] [Related]
17. Lobaplatin promotes radiosensitivity, induces apoptosis, attenuates cancer stemness and inhibits proliferation through PI3K/AKT pathway in esophageal squamous cell carcinoma.
Pan S; Sun Y; Sui D; Yang T; Fu S; Wang J; Hui B; Xi R; He C; Zhang X
Biomed Pharmacother; 2018 Jun; 102():567-574. PubMed ID: 29597090
[TBL] [Abstract][Full Text] [Related]
18. CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma.
Zhang H; Yue J; Jiang Z; Zhou R; Xie R; Xu Y; Wu S
Cell Death Dis; 2017 May; 8(5):e2790. PubMed ID: 28518141
[TBL] [Abstract][Full Text] [Related]
19. FLI-06 suppresses proliferation, induces apoptosis and cell cycle arrest by targeting LSD1 and Notch pathway in esophageal squamous cell carcinoma cells.
Lu Z; Ren Y; Zhang M; Fan T; Wang Y; Zhao Q; Liu HM; Zhao W; Hou G
Biomed Pharmacother; 2018 Nov; 107():1370-1376. PubMed ID: 30257352
[TBL] [Abstract][Full Text] [Related]
20. eEF2K promotes progression and radioresistance of esophageal squamous cell carcinoma.
Zhu H; Song H; Chen G; Yang X; Liu J; Ge Y; Lu J; Qin Q; Zhang C; Xu L; Di X; Cai J; Ma J; Zhang S; Sun X
Radiother Oncol; 2017 Sep; 124(3):439-447. PubMed ID: 28431753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
